Sai Parenterals rallied 3.33% to Rs 544.15 after the company announced that its subsidiary, Noumed Pharmaceuticals, has renewed its OTC Medicines Supply Agreement with one of Australia’s leading multi-billion-dollar pharmacy chains.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.